65 related articles for article (PubMed ID: 8879979)
1. Does the appearance of drug resistance during therapy alter bacterial susceptibility to opsonophagocytosis?
Gemmell CG
Drugs Exp Clin Res; 1996; 22(2):51-5. PubMed ID: 8879979
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients.
Dryden MS; Talsania H; McCann M; Cookson BD; Phillips I
Epidemiol Infect; 1992 Aug; 109(1):97-112. PubMed ID: 1499676
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E
Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
[TBL] [Abstract][Full Text] [Related]
4. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
[TBL] [Abstract][Full Text] [Related]
6. Treatment of CAPD-related peritonitis with ciprofloxacin: results after seven years.
Bouza P; García Falcón T; Pérez Fontán M; Rodríguez-Carmona A; López Vázquez M; Tresancos C; Valdés F
Adv Perit Dial; 1996; 12():185-8. PubMed ID: 8865898
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of coagulase-negative Staphylococcus species isolated from bovine milk.
Sawant AA; Gillespie BE; Oliver SP
Vet Microbiol; 2009 Feb; 134(1-2):73-81. PubMed ID: 18950969
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic characteristics of coagulase-negative staphylococci: typing and antibiotic susceptibility.
Jarløv JO
APMIS Suppl; 1999; 91():1-42. PubMed ID: 10230367
[TBL] [Abstract][Full Text] [Related]
9. [Occurrence of high-level mupirocin resistant coagulase-negative staphylococci in hospitals and their characterization].
Wiśniewska K; Michnowska-Swincow E; Galiński J
Med Dosw Mikrobiol; 2004; 56(3):217-23. PubMed ID: 15773497
[TBL] [Abstract][Full Text] [Related]
10. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
Sharma V; Sharma S; Garg P; Rao GN
Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological profile of linezolid-resistant coagulase-negative staphylococci.
Potoski BA; Adams J; Clarke L; Shutt K; Linden PK; Baxter C; Pasculle AW; Capitano B; Peleg AY; Szabo D; Paterson DL
Clin Infect Dis; 2006 Jul; 43(2):165-71. PubMed ID: 16779742
[TBL] [Abstract][Full Text] [Related]
12. Linezolid resistance in coagulase-negative staphylococci.
Kelly S; Collins J; Davin M; Gowing C; Murphy PG
J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
[No Abstract] [Full Text] [Related]
13. [Survey on drug resistance to ciprofloxacin in common pathogenic bacteria].
Zhang YL; Geng SN; Lai FC; Wang NP
Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):378-9. PubMed ID: 12390755
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.
Boisson K; Thouverez M; Talon D; Bertrand X
Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening.
Nunes AP; Teixeira LM; Iorio NL; Bastos CC; de Sousa Fonseca L; Souto-Padrón T; dos Santos KR
Int J Antimicrob Agents; 2006 Apr; 27(4):307-15. PubMed ID: 16542825
[TBL] [Abstract][Full Text] [Related]
17. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey.
Koksal F; Yasar H; Samasti M
Microbiol Res; 2009; 164(4):404-10. PubMed ID: 17475456
[TBL] [Abstract][Full Text] [Related]
19. [Sensitivity to vancomycin and teicoplanin of coagulase-negative staphylococci isolated from clinical specimens].
Młynarczyk G; Młynarczyk A; Luczak M; Jeljaszewicz J
Med Dosw Mikrobiol; 1999; 51(1-2):17-23. PubMed ID: 10865426
[TBL] [Abstract][Full Text] [Related]
20. [Constitutive and inducible clindamycin resistance among nosocomially acquired staphylococci].
Dizbay M; Günal O; Ozkan Y; Ozcan Kanat D; Altunçekiç A; Arman D
Mikrobiyol Bul; 2008 Apr; 42(2):217-21. PubMed ID: 18697419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
